HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“Chemophobia” rampant

This article was originally published in The Rose Sheet

Executive Summary

Consumers' perception of chemicals amounts to "chemophobia" - a fear and distrust of chemicals that is not proportionate to their actual risk, according to Dan Gardner, columnist and senior writer for the Ottawa Citizen and author of the book, "The Science of Fear: Why We Fear Things We Shouldn't - And Put Ourselves in Greater Danger." Speaking at a Feb. 25 session of the Personal Care Products Council's annual meeting in Boca Raton, Fla., Gardner cited a study led by risk assessment researcher Dr. Paul Slovic to gauge the public's perception of chemicals in the U.S., UK and Canada. In the study, 75% of participants in each country said they try to avoid chemicals and would not drink water if it contained "even a tiny amount of a carcinogen," roughly 70% that someone exposed to a carcinogen will probably get cancer, and 60% that it is never too expensive to reduce the risk from chemicals, according to Gardner. Chemophobia "drives up the perception of risk," the journalist said. On the other hand, consumer perception of the term "natural" is "as strongly positive as 'chemical' is negative." Gardner suggested that industry adopt a "capitulate-or-fight" strategy - either go green or band together with other consumer product sectors such as the food industry to offer a response "as big and as deep as the problem.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015990

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel